To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene BFARTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
431 supporting clones for gene BFAR back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_016561.2   .a 1 to 3042 1 to 3042 exact RefSeq, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 3042/3042
(100 %)
0 diff
(100 %id)
CN482741 eye .a 5 to 668 1 to 664   tiling clone,   664/665
(99 %)
1 diff
(99.9 %id)
BQ067783 brain .a 25 to 839 12 to 830       819/1087
(75 %)
14 diff
(98.8 %id)
DN993308 brain, whole brain .a 92 to 764 1 to 672       672/672
(100 %)
5 diff
(99.3 %id)
BE619329 large cell carcinoma, lung .a 100 to 797 1 to 695       695/953
(72 %)
12 diff
(98.8 %id)
BX953765   .a 105 to 663 1 to 559       559/559
(100 %)
0 diff
(100 %id)
DB464964 hippocampus .a 113 to 545 1 to 430       430/439
(97 %)
7 diff
(98.5 %id)
DB483143 hippocampus .a 113 to 607 1 to 495       495/495
(100 %)
0 diff
(100 %id)
TI_57219484   .a 120 to 891 31 to 805       775/805
(96 %)
9 diff
(98.9 %id)
BX416231 neuroblastoma .a 123 to 463 1 to 340       340/340
(100 %)
2 diff
(99.5 %id)
BX381159 Placenta Cot 25-normalized .a 123 to 745 1 to 638       638/638
(100 %)
22 diff
(96.6 %id)
BI825002 pooled brain, lung, testis .a 123 to 708 25 to 607       583/607
(96 %)
7 diff
(98.9 %id)
TI_57197821   .a 123 to 708 25 to 607       583/607
(96 %)
7 diff
(98.9 %id)
DB477866 hippocampus .a 124 to 404 1 to 281       281/284
(98 %)
4 diff
(98.6 %id)
CN363497 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 127 to 660 1 to 534       534/534
(100 %)
1 diff
(99.9 %id)
BE314534 brain, neuroblastoma .a 128 to 922 17 to 802       786/820
(95 %)
21 diff
(97.5 %id)
AF173003   .a 129 to 2642 1 to 2514 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 2514/2514
(100 %)
13 diff
(99.5 %id)
BG826870 muscle, rhabdomyosarcoma .a 129 to 790 1 to 663       663/663
(100 %)
2 diff
(99.7 %id)
BI114412 muscle, rhabdomyosarcoma .a 129 to 921 1 to 788       788/826
(95 %)
20 diff
(97.6 %id)
CX784114 human embryonic stem cells .a 129 to 693 1 to 565       565/565
(100 %)
4 diff
(99.3 %id)
BI753727 brain .a 130 to 891 1 to 766       766/766
(100 %)
5 diff
(99.4 %id)
TI_57217411   .a 130 to 891 69 to 838       770/1254
(61 %)
19 diff
(98.5 %id)
DR157529 human embryonic stem cells differentiated toan early endodermal cell type .a 131 to 916 1 to 786       786/786
(100 %)
1 diff
(99.9 %id)
CD656233 Embryonic Stem cells .a 131 to 851 12 to 729       718/813
(88 %)
17 diff
(98.0 %id)
T35285 prostate gland .a 131 to 498 1 to 368       368/368
(100 %)
4 diff
(99.0 %id)
F05632 brain, total brain .a 133 to 363 1 to 230       230/230
(100 %)
1 diff
(99.6 %id)
Z44193 brain, total brain .a 133 to 410 1 to 278       278/278
(100 %)
0 diff
(100 %id)
BG760209 melanotic melanoma, high MDR (cell line), skin .a 133 to 893 1 to 760       760/761
(99 %)
5 diff
(99.4 %id)
BI754710 brain .a 133 to 891 1 to 767       767/1183
(64 %)
13 diff
(99.0 %id)
BM194259 leukopheresis .a 134 to 531 1 to 398       398/398
(100 %)
11 diff
(97.3 %id)
R12025 whole brain .a 135 to 444 1 to 314       314/468
(67 %)
10 diff
(97.9 %id)
BG248512 adenocarcinoma cell line, colon .a 136 to 922 1 to 778       778/778
(100 %)
13 diff
(98.4 %id)
BQ877878 dorsal root ganglia .a 142 to 1005 1 to 873       873/901
(96 %)
12 diff
(98.7 %id)
TI_57148343   .a 142 to 969 67 to 899       833/899
(92 %)
14 diff
(98.5 %id)
CD628014   .a 143 to 784 29 to 665       637/665
(95 %)
15 diff
(97.8 %id)
BI759664 pooled colon, kidney, stomach .a 143 to 969 1 to 832       832/832
(100 %)
8 diff
(99.1 %id)
BM450677 eye, retinoblastoma .a 143 to 916 1 to 787       787/1020
(77 %)
16 diff
(98.5 %id)
DB469614 hippocampus .a 144 to 581 1 to 438       438/438
(100 %)
1 diff
(99.8 %id)
CN363496 embryonic stem cells, cell lines H1, H7, andH9 .a 145 to 528 1 to 384       384/384
(100 %)
6 diff
(98.5 %id)
BI715165 Pancreas, Purified pancreatic islet .a 146 to 640 1 to 495       495/495
(100 %)
0 diff
(100 %id)
T35906 blood, white blood cells .a 146 to 422 1 to 278       278/278
(100 %)
1 diff
(99.7 %id)
CX788585 human embryonic stem cells .a 147 to 856 1 to 710       710/710
(100 %)
1 diff
(99.9 %id)
DB465635 hippocampus .a 148 to 566 1 to 419       419/419
(100 %)
2 diff
(99.6 %id)
BE797036 lung, small cell carcinoma .a 150 to 999 1 to 844       844/848
(99 %)
23 diff
(97.3 %id)
BI912008 leukocyte .a 150 to 890 22 to 766       745/767
(97 %)
17 diff
(97.8 %id)
TI_57234798   .a 150 to 890 22 to 766       745/767
(97 %)
17 diff
(97.8 %id)
BE787761 large cell carcinoma, lung .a 152 to 908 1 to 749       749/863
(86 %)
21 diff
(97.6 %id)
BG319590 skin .a 154 to 513 1 to 360       360/360
(100 %)
0 diff
(100 %id)
CN363499 embryonic stem cells, cell lines H1, H7, andH9 .a 155 to 815 1 to 662       662/662
(100 %)
3 diff
(99.6 %id)
AL561344 B cells from Burkitt lymphoma .a 155 to 1059 1 to 904       904/912
(99 %)
29 diff
(96.9 %id)
AL540546 placenta .a 156 to 1058 1 to 902       902/902
(100 %)
1 diff
(99.9 %id)
AL550826 placenta, Placenta Cot 25-normalized .a 156 to 1205 1 to 1044       1044/1050
(99 %)
10 diff
(99.1 %id)
BX366953   .a 156 to 999 1 to 844       844/844
(100 %)
0 diff
(100 %id)
AL558813 T cells from T cell leukemia .a 156 to 1007 1 to 852       852/852
(100 %)
1 diff
(99.9 %id)
BQ229180 melanotic melanoma, skin .a 156 to 846 24 to 716       693/945
(73 %)
16 diff
(98.4 %id)
AL552529 placenta, Placenta Cot 25-normalized .a 157 to 1143 1 to 982       982/982
(100 %)
5 diff
(99.5 %id)
AL553319 placenta, Placenta Cot 25-normalized .a 157 to 1064 1 to 905       905/905
(100 %)
7 diff
(99.3 %id)
CX756434 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 157 to 887 1 to 731     Submitted on the opposite strand 731/731
(100 %)
3 diff
(99.6 %id)
BX403870 neuroblastoma .a 158 to 1231 1 to 1067       1067/1071
(99 %)
14 diff
(98.7 %id)
BG824202 adenocarcinoma cell line, colon .a 160 to 964 1 to 804       804/804
(100 %)
12 diff
(98.6 %id)
CD653827 Embryonic Stem cells .a 160 to 922 4 to 765       762/825
(92 %)
15 diff
(98.2 %id)
BQ957728 large cell carcinoma, lung .a 163 to 1065 1 to 904       904/935
(96 %)
2 diff
(99.8 %id)
AL528521 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 164 to 1064 34 to 933       900/933
(96 %)
11 diff
(98.9 %id)
BQ876945 epidermoid carcinoma, cell line, lung .a 166 to 751 1 to 586       586/1068
(54 %)
5 diff
(99.6 %id)
BC003054 Lung, small cell carcinoma .a 170 to 2666 1 to 2497 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 2497/2497
(100 %)
1 diff
(100.0 %id)
AL516848 brain, neuroblastoma, neuroblastoma cells .a 170 to 1064 1 to 894       894/894
(100 %)
3 diff
(99.7 %id)
BE408506 choriocarcinoma, placenta .a 170 to 895 1 to 718       718/753
(95 %)
13 diff
(98.3 %id)
BG477636 melanotic melanoma, skin .a 170 to 977 1 to 819       817/891
(91 %)
21 diff
(97.7 %id)
BG476975 melanotic melanoma, skin .a 170 to 806 1 to 637       637/637
(100 %)
6 diff
(99.1 %id)
AA021128 eye, retina .a 171 to 622 1 to 464       464/464
(100 %)
16 diff
(96.6 %id)
BE407256 choriocarcinoma, placenta .a 171 to 866 1 to 693       693/693
(100 %)
8 diff
(98.9 %id)
BE302826 melanotic melanoma, skin .a 172 to 765 1 to 594       594/594
(100 %)
3 diff
(99.5 %id)
BG168745 hypernephroma, cell line, Kidney .a 172 to 912 1 to 744       744/868
(85 %)
21 diff
(97.6 %id)
BM478991 melanotic melanoma, skin .a 172 to 851 1 to 680       680/1143
(59 %)
6 diff
(99.5 %id)
CD652749 Embryonic Stem cells .a 172 to 847 12 to 683       672/803
(83 %)
16 diff
(98.1 %id)
BI771174 pooled lung and spleen .a 173 to 755 1 to 627       555/777
(71 %)
50 diff
(93.6 %id)
BI769595 pooled lung and spleen .a 173 to 1117 1 to 943       943/945
(99 %)
20 diff
(97.9 %id)
BQ424106 eye, retinoblastoma .a 173 to 868 1 to 704       704/786
(89 %)
12 diff
(98.5 %id)
TI_57179294   .a 173 to 755 30 to 656       555/806
(68 %)
54 diff
(93.4 %id)
TI_57179374   .a 173 to 1117 100 to 1042       943/1044
(90 %)
26 diff
(97.6 %id)
BI438495 Pancreas, Purified pancreatic islet .a 174 to 764 1 to 591       591/591
(100 %)
1 diff
(99.9 %id)
BM312046 Pancreas, Purified pancreatic islet .a 175 to 699 1 to 525       525/525
(100 %)
0 diff
(100 %id)
BU076524 Pancreas, Purified pancreatic islet .a 175 to 816 1 to 642       642/642
(100 %)
1 diff
(99.9 %id)
CD655109 Embryonic Stem cells .a 175 to 963 12 to 796       785/807
(97 %)
19 diff
(97.7 %id)
BE256065 eye, retinoblastoma .a 176 to 741 1 to 568       568/568
(100 %)
6 diff
(99.0 %id)
BE251536 eye, retinoblastoma .a 176 to 882 1 to 701       701/703
(99 %)
12 diff
(98.3 %id)
BG747056 adenocarcinoma cell line, colon .a 179 to 1041 1 to 863       863/863
(100 %)
30 diff
(96.6 %id)
BG324753 Kidney, renal cell adenocarcinoma .a 180 to 774 1 to 594       594/594
(100 %)
1 diff
(99.9 %id)
T09074   .a 181 to 479 1 to 301       301/301
(100 %)
2 diff
(99.4 %id)
BG117496 adenocarcinoma, cell line, Liver .a 181 to 869 1 to 686       686/945
(72 %)
14 diff
(98.6 %id)
BM475315 eye, retinoblastoma .a 182 to 1065 1 to 886       886/1057
(83 %)
10 diff
(99.1 %id)
BM045403 carcinoma, cell line, Prostate .a 184 to 921 1 to 750       750/899
(83 %)
31 diff
(96.6 %id)
CD557395 testis .a 184 to 979 31 to 839       807/918
(87 %)
25 diff
(97.3 %id)
BE251889 eye, retinoblastoma .a 185 to 545 1 to 361       361/401
(90 %)
6 diff
(98.6 %id)
DA946844 Spleen .a 186 to 753 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
BE266639 lung, small cell carcinoma .a 189 to 823 1 to 634       634/757
(83 %)
11 diff
(98.6 %id)
BE384830 melanotic melanoma, skin .a 190 to 661 1 to 472       472/472
(100 %)
1 diff
(99.8 %id)
AK291114   .a 193 to 1812 1 to 1620 exact     1620/1620
(100 %)
2 diff
(99.9 %id)
AK313890   .a 193 to 1634 1 to 1442 L352S V354F     1442/1442
(100 %)
2 diff
(99.9 %id)
BP242793 Liver .a 193 to 756 1 to 564       564/580
(97 %)
17 diff
(97.1 %id)
DA032777   .a 194 to 751 2 to 559   capped   558/562
(99 %)
3 diff
(99.5 %id)
DA052756   .a 194 to 739 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA479332   .a 194 to 772 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DA490231 brain .a 194 to 703 2 to 511   capped   510/512
(99 %)
1 diff
(99.9 %id)
BE874538 large cell carcinoma, undifferentiated, lung .a 194 to 888 1 to 705       705/1125
(62 %)
26 diff
(97.7 %id)
BE887732 leiomyosarcoma, uterus .a 194 to 936 1 to 741       741/829
(89 %)
18 diff
(97.9 %id)
DA652006   .a 194 to 760 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA733828   .a 194 to 810 2 to 619   capped   618/627
(98 %)
6 diff
(99.1 %id)
DA736420   .a 194 to 1063 2 to 872   capped   871/884
(98 %)
6 diff
(99.4 %id)
DA737399   .a 194 to 1019 2 to 834   capped   833/915
(91 %)
11 diff
(98.8 %id)
DA825966 pericardium .a 194 to 762 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA884890   .a 194 to 746 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA970090 stomach .a 194 to 751 2 to 559   capped   558/562
(99 %)
2 diff
(99.7 %id)
N30481 melanocyte .a 203 to 638 1 to 436       436/438
(99 %)
2 diff
(99.6 %id)
BG323716 Kidney, renal cell adenocarcinoma .a 209 to 1062 1 to 853       853/855
(99 %)
15 diff
(98.3 %id)
BG424301 Kidney, renal cell adenocarcinoma .a 209 to 912 1 to 703       703/704
(99 %)
16 diff
(97.8 %id)
BG114238 Bone, osteosarcoma, cell line .a 237 to 919 1 to 686       686/686
(100 %)
6 diff
(99.2 %id)
DA735744   .a 245 to 968 2 to 725   capped   724/724
(100 %)
0 diff
(100 %id)
DA709511   .a 246 to 815 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA734103   .a 248 to 897 2 to 652   capped   651/655
(99 %)
5 diff
(99.3 %id)
DA948092 Spleen .a 258 to 818 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA653007   .a 263 to 814 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
TI_1948094198   .a 281 to 1052 134 to 913       780/1190
(65 %)
21 diff
(98.3 %id)
TI_1948094638   .a 281 to 849 133 to 706       574/1255
(45 %)
21 diff
(98.4 %id)
CV025910 mixed .a 282 to 900 1 to 619       619/619
(100 %)
0 diff
(100 %id)
BM556829 amelanotic melanoma, cell line, skin .a 284 to 793 1 to 510       510/1082
(47 %)
9 diff
(99.2 %id)
BP281915 bone marrow .a 292 to 872 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
BM830096 stomach .a 292 to 889 1 to 598       598/598
(100 %)
0 diff
(100 %id)
BG325434 Kidney, renal cell adenocarcinoma .a 294 to 912 1 to 618       618/619
(99 %)
4 diff
(99.4 %id)
BG325343 Kidney, renal cell adenocarcinoma .a 294 to 1057 1 to 770       770/773
(99 %)
15 diff
(98.1 %id)
BP329824 rectum .a 302 to 888 1 to 588       588/588
(100 %)
7 diff
(98.9 %id)
BE613878 leiomyosarcoma, uterus .a 307 to 819 1 to 512     Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 512/512
(100 %)
2 diff
(99.7 %id)
DA376968 thalamus .a 334 to 885 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
BQ307001 breast .a 349 to 903 1 to 552       552/552
(100 %)
14 diff
(97.5 %id)
DA019291   .a 370 to 925 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
BP255826 Kidney .a 377 to 958 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA733270   .a 408 to 1065 2 to 662   capped   659/665
(99 %)
15 diff
(97.8 %id)
BP268778 thyroid .a 419 to 1001 1 to 584       584/584
(100 %)
2 diff
(99.7 %id)
BE018503 cervix .a 430 to 893 1 to 464       464/464
(100 %)
2 diff
(99.6 %id)
BF795032 lymph, lymphoma, cell line .a 435 to 1159 1 to 717       717/977
(73 %)
18 diff
(98.2 %id)
CA488721   .a 468 to 1338 1 to 881       881/908
(97 %)
23 diff
(97.5 %id)
BG281462 melanotic melanoma, skin .a 491 to 1375 1 to 882       882/949
(92 %)
18 diff
(98.2 %id)
BG281541 melanotic melanoma, skin .a 492 to 1415 1 to 919       921/1034
(89 %)
29 diff
(97.2 %id)
BE302562 melanotic melanoma, skin .a 498 to 833 1 to 336       336/336
(100 %)
0 diff
(100 %id)
BQ270753 insulinoma, Pancreas .a 504 to 1044 8 to 548     Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 541/548
(98 %)
0 diff
(100 %id)
BE277256 melanotic melanoma, skin .a 511 to 1238 1 to 725       725/784
(92 %)
6 diff
(99.3 %id)
BF025874 melanotic melanoma, skin .a 511 to 1171 1 to 667       667/897
(74 %)
11 diff
(98.8 %id)
BE274654 melanotic melanoma, skin .a 512 to 1291 1 to 775       775/804
(96 %)
11 diff
(98.7 %id)
CD628013   .a 557 to 1307 758 to 6       753/758
(99 %)
4 diff
(99.5 %id)
BI859125 breast, mammary adenocarcinoma, cell line .a 560 to 1292 1 to 734       734/734
(100 %)
1 diff
(99.9 %id)
TI_57188084   .a 560 to 1292 49 to 782       734/734
(100 %)
1 diff
(99.9 %id)
BP345970 synovial membrane .a 560 to 1140 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
CB146983 Liver .a 564 to 1199 1 to 636       636/636
(100 %)
0 diff
(100 %id)
DA730769   .a 596 to 1420 2 to 819   capped   818/821
(99 %)
13 diff
(98.5 %id)
BX363831   .a 621 to 1619 1 to 990       990/996
(99 %)
18 diff
(98.2 %id)
EC481159 Prostate .a 622 to 726 1 to 105       105/105
(100 %)
1 diff
(99.1 %id)
EC509765 Prostate .a 622 to 726 1 to 99       99/99
(100 %)
6 diff
(94.0 %id)
BP242916 Liver .a 632 to 1218 1 to 587       587/587
(100 %)
4 diff
(99.4 %id)
EC568138 Prostate .a 634 to 726 17 to 105       89/105
(84 %)
6 diff
(94.3 %id)
DA276068 corpus callosum .a 643 to 1173 2 to 533   capped   532/532
(100 %)
1 diff
(99.9 %id)
BF971239 adrenal cortex carcinoma, cell line, adrenal gland .a 695 to 1447 1 to 753       753/942
(79 %)
9 diff
(99.1 %id)
BU177506 melanotic melanoma, skin .a 706 to 1532 35 to 873       839/879
(95 %)
39 diff
(95.6 %id)
BE300516 melanotic melanoma, skin .a 768 to 832 65 to 1       65/65
(100 %)
0 diff
(100 %id)
BQ278227 mixed (pool of 40 RNAs) .a 816 to 1551 1 to 746       746/902
(82 %)
14 diff
(98.5 %id)
AA181590   .a 819 to 1120 5 to 305       301/305
(98 %)
7 diff
(97.8 %id)
BU942681 mixed (pool of 40 RNAs) .a 862 to 1646 1 to 794       794/797
(99 %)
12 diff
(98.5 %id)
TI_1948094484   .a 907 to 1633 863 to 134     Submitted on the opposite strand 730/1223
(59 %)
11 diff
(99.2 %id)
BX487642   .a 918 to 1477 47 to 605       559/605
(92 %)
6 diff
(99.1 %id)
CB054940 brain, glioblastoma (pooled) .a 918 to 1615 13 to 710       698/710
(98 %)
6 diff
(99.2 %id)
TI_227716957   .a 920 to 1763 928 to 88   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 841/1004
(83 %)
7 diff
(99.4 %id)
TI_151733190   .a 959 to 1758 875 to 78   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 798/972
(82 %)
6 diff
(99.4 %id)
BQ188840 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 961 to 1269 1 to 309   fully sequenced, Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 309/309
(100 %)
0 diff
(100 %id)
BU659276 blood .a 969 to 1487 14 to 532       519/532
(97 %)
6 diff
(98.9 %id)
AW806578 stomach .a 973 to 1517 546 to 3       544/546
(99 %)
1 diff
(99.9 %id)
BE870602 adenocarcinoma, colon .a 991 to 1753 1 to 755       755/1046
(72 %)
45 diff
(95.7 %id)
R58120   .a 999 to 1273 1 to 274       274/274
(100 %)
7 diff
(97.5 %id)
CR746500 melanotic melanoma, skin .a 1002 to 1449 59 to 505       447/505
(88 %)
6 diff
(98.9 %id)
BQ424556 melanotic melanoma, skin .a 1002 to 1822 47 to 877       831/893
(93 %)
26 diff
(97.1 %id)
DA505954 brain .a 1058 to 1589 2 to 533   capped   532/532
(100 %)
1 diff
(99.9 %id)
BX433429 adult brain, brain .a 1063 to 1839 795 to 23       773/795
(97 %)
11 diff
(98.7 %id)
Z45333 brain, total brain .a 1072 to 1407 1 to 336       336/336
(100 %)
0 diff
(100 %id)
F07972 brain, total brain .a 1072 to 1389 1 to 318       318/318
(100 %)
0 diff
(100 %id)
BF991251 placenta_normal .a 1095 to 1548 468 to 16       453/468
(96 %)
1 diff
(99.8 %id)
AL516847 brain, neuroblastoma, neuroblastoma cells .a 1105 to 2124 1017 to 1       1017/1017
(100 %)
43 diff
(95.8 %id)
BG122732 adenocarcinoma, cell line, Liver .a 1117 to 1832 8 to 722   AAA   715/948
(75 %)
24 diff
(97.5 %id)
BU191811 epithelioid carcinoma, Pancreas .a 1133 to 2029 1 to 902       902/906
(99 %)
13 diff
(98.6 %id)
BG388745 embryonal carcinoma, cell line, testis .a 1149 to 1916 1 to 761       761/818
(93 %)
16 diff
(98.1 %id)
AL568470 placenta .a 1156 to 2121 970 to 1       970/970
(100 %)
32 diff
(96.8 %id)
CD364317 Alveolar Macrophage, lung .a 1171 to 1763 611 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 593/593
(100 %)
0 diff
(100 %id)
CK301197 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1208 to 1758 569 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 551/551
(100 %)
0 diff
(100 %id)
BP328811 rectum .a 1242 to 1823 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BG031786 breast, mammary adenocarcinoma, cell line .a 1243 to 1872 1 to 628       628/968
(64 %)
8 diff
(99.2 %id)
AA096046   .a 1252 to 1474 56 to 277       222/280
(79 %)
8 diff
(97.2 %id)
BQ440973 melanotic melanoma, skin .a 1256 to 2105 12 to 864       853/870
(98 %)
16 diff
(98.2 %id)
BM803085 duodenal adenocarcinoma, cell line, small intestine .a 1258 to 1671 1 to 415       415/1413
(29 %)
11 diff
(99.3 %id)
Z45856 brain, total brain .a 1272 to 1621 1 to 350       350/350
(100 %)
0 diff
(100 %id)
BX452578 adult brain, brain .a 1309 to 1925 13 to 630       618/819
(75 %)
38 diff
(95.4 %id)
BE160865 head_neck .a 1350 to 1975 1 to 626       626/627
(99 %)
8 diff
(98.8 %id)
BE160926 head_neck .a 1352 to 1938 13 to 602       590/605
(97 %)
37 diff
(93.9 %id)
BP255921 Kidney .a 1372 to 1952 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
CB215228 normal endometrium, late proliferativephase, cycle day 13, uterus .a 1390 to 1932 1 to 543       543/543
(100 %)
0 diff
(100 %id)
BF980855 duodenal adenocarcinoma, cell line, small intestine .a 1424 to 2164 1 to 750       750/869
(86 %)
13 diff
(98.6 %id)
AA171676   .a 1442 to 1720 1 to 278       278/278
(100 %)
3 diff
(99.0 %id)
BI821349 pooled brain, lung, testis .a 1463 to 2232 1 to 765       765/765
(100 %)
6 diff
(99.3 %id)
TI_57200498   .a 1463 to 2232 37 to 801       765/801
(95 %)
6 diff
(99.3 %id)
CF242861 Brain glioblastoma .a 1529 to 2404 1 to 879       879/883
(99 %)
9 diff
(99.0 %id)
AW390336 stomach .a 1530 to 2039 513 to 1       513/516
(99 %)
14 diff
(97.3 %id)
AA460071   .a 1541 to 2042 1 to 501       501/501
(100 %)
2 diff
(99.7 %id)
CA439795 lung, Lung Focal Fibrosis .a 1544 to 2134 8 to 598   AAA Submitted on the opposite strand 591/598
(98 %)
6 diff
(99.0 %id)
BG030783 breast, mammary adenocarcinoma, cell line .a 1565 to 2429 1 to 864       864/870
(99 %)
42 diff
(95.2 %id)
BP317535 pericardium .a 1577 to 2151 1 to 575       575/581
(98 %)
7 diff
(98.8 %id)
AA326030 brain, cerebellum .a 1583 to 1915 1 to 341       341/370
(92 %)
11 diff
(97.1 %id)
AW952375   .a 1584 to 2247 1 to 664       664/665
(99 %)
4 diff
(99.4 %id)
R91016 liver and spleen .a 1613 to 2022 1 to 412       412/419
(98 %)
6 diff
(98.6 %id)
BE501405 Kidney .a 1625 to 2149 526 to 2       525/526
(99 %)
0 diff
(100 %id)
EC443669 Prostate .a 1628 to 1722 95 to 1       95/95
(100 %)
0 diff
(100 %id)
EC500692 Prostate .a 1628 to 1726 100 to 1       100/100
(100 %)
4 diff
(96.0 %id)
BU943913 adenocarcinoma, cell line, breast .a 1634 to 2528 1 to 899       899/930
(96 %)
5 diff
(99.5 %id)
AI888470 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 1647 to 2145 499 to 1       499/499
(100 %)
0 diff
(100 %id)
AL564908 adult brain, brain .a 1677 to 2646 968 to 1       968/1031
(93 %)
12 diff
(98.9 %id)
BE858432 brain, glioblastoma (pooled) .a 1678 to 2138 461 to 1       461/461
(100 %)
0 diff
(100 %id)
AA303856 aorta .a 1682 to 2084 1 to 405       405/405
(100 %)
4 diff
(99.1 %id)
AL528491 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 1685 to 2668 981 to 1       981/981
(100 %)
21 diff
(97.9 %id)
BF793448 adrenal cortex carcinoma, cell line, adrenal gland .a 1686 to 2092 1 to 412       412/412
(100 %)
3 diff
(99.3 %id)
AI114830 Liver .a 1694 to 2308 1 to 624       624/624
(100 %)
12 diff
(98.1 %id)
DW435984 Liver .a 1730 to 1967 17 to 254       238/254
(93 %)
6 diff
(97.7 %id)
DW438061 Liver .a 1730 to 1960 17 to 247       231/247
(93 %)
6 diff
(97.6 %id)
DW466291 Liver .a 1730 to 2066 17 to 353       337/353
(95 %)
6 diff
(98.4 %id)
TI_149285400   .a 1746 to 2668 978 to 72       907/1198
(75 %)
0 diff
(100 %id)
AL576345 placenta, Placenta Cot 25-normalized .a 1751 to 2753 992 to 1       992/1016
(97 %)
16 diff
(98.5 %id)
AA625438 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1764 to 2328 1 to 565       565/565
(100 %)
1 diff
(99.9 %id)
BQ086255 Islets of Langerhans, Pancreas .a 1775 to 2227 1 to 453       453/457
(99 %)
1 diff
(99.8 %id)
AA664410 lung .a 1786 to 2137 353 to 2       352/353
(99 %)
0 diff
(100 %id)
BM129678 Islets of Langerhans, Pancreas .a 1791 to 2137 1 to 347       347/347
(100 %)
0 diff
(100 %id)
BG032767 breast, mammary adenocarcinoma, cell line .a 1812 to 2574 1 to 749       749/907
(82 %)
27 diff
(97.1 %id)
BQ185738 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1814 to 2304 1 to 491       491/523
(93 %)
2 diff
(99.7 %id)
BE160871 head_neck .a 1833 to 2461 631 to 2     Submitted on the opposite strand 630/634
(99 %)
0 diff
(100 %id)
TI_154062320   .a 1847 to 2642 849 to 61   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 789/931
(84 %)
14 diff
(98.5 %id)
AW606819 head_neck .a 1889 to 2479 596 to 12       585/596
(98 %)
0 diff
(100 %id)
CF454305 peripheral nervous system .a 1901 to 2740 34 to 864       831/927
(89 %)
13 diff
(98.6 %id)
AA181642   .a 1921 to 2346 426 to 1       426/426
(100 %)
2 diff
(99.6 %id)
BF980608 duodenal adenocarcinoma, cell line, small intestine .a 1940 to 2573 12 to 643       632/981
(64 %)
6 diff
(99.4 %id)
AL574694 placenta, Placenta Cot 25-normalized .a 1949 to 3003 1040 to 1       1040/1102
(94 %)
20 diff
(98.2 %id)
BQ574877 Chondrosarcoma Grade II, Left Pelvis .a 1949 to 2642 711 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 693/693
(100 %)
3 diff
(99.6 %id)
TI_57192044   .a 1957 to 2607 51 to 721   AAA   671/712
(94 %)
23 diff
(96.8 %id)
BI862685 breast, mammary adenocarcinoma, cell line .a 1959 to 2607 1 to 669   AAA   669/710
(94 %)
23 diff
(96.8 %id)
AI969009 pooled germ cell tumors .a 1966 to 2145 180 to 1       180/180
(100 %)
1 diff
(99.5 %id)
AW264634 brain, three pooled meningiomas .a 1968 to 2218 251 to 1       251/251
(100 %)
2 diff
(99.3 %id)
BG751613 eye, normal pigmented retinal epithelium .a 1978 to 2634 1 to 657       657/657
(100 %)
1 diff
(99.9 %id)
BU154341 eye, retinoblastoma .a 1982 to 2863 1 to 886       886/886
(100 %)
11 diff
(98.8 %id)
BM990086 lung, Lung Focal Fibrosis .a 1999 to 2642 662 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 644/644
(100 %)
0 diff
(100 %id)
CA421112 Bone, Enchondroma cell line .a 2006 to 2642 655 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 637/637
(100 %)
0 diff
(100 %id)
BU680841 lung .a 2007 to 2642 654 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 636/636
(100 %)
1 diff
(99.9 %id)
AW238824 lung, cell line .a 2009 to 2436 1 to 428       428/428
(100 %)
1 diff
(99.8 %id)
CF127694 Chondrosarcoma Lung Metastasis cell lines, lung .a 2025 to 2644 1 to 621       621/629
(98 %)
3 diff
(99.6 %id)
TI_154193260   .a 2025 to 2813 51 to 840   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 790/790
(100 %)
7 diff
(99.2 %id)
BI053952 placenta_normal .a 2027 to 2462 468 to 37       432/468
(92 %)
0 diff
(100 %id)
AA356807   .a 2038 to 2329 1 to 292       292/292
(100 %)
0 diff
(100 %id)
ES315242 occipital scalp hair, skin .a 2040 to 2220 1 to 180       180/180
(100 %)
1 diff
(99.5 %id)
AL575914 placenta, Placenta Cot 25-normalized .a 2042 to 3012 970 to 1       970/970
(100 %)
8 diff
(99.2 %id)
DB366128   .a 2048 to 2642 594 to 1       594/596
(99 %)
13 diff
(97.9 %id)
CB217364 mandible, pooled .a 2051 to 2570 1 to 520   fully sequenced, Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 520/520
(100 %)
0 diff
(100 %id)
BE879362 large cell carcinoma, undifferentiated, lung .a 2061 to 2765 1 to 698       698/804
(86 %)
17 diff
(97.9 %id)
BE966257 leiomyosarcoma, uterus .a 2076 to 2700 636 to 15   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 622/923
(67 %)
0 diff
(100 %id)
DB369992   .a 2076 to 2642 564 to 1       564/567
(99 %)
6 diff
(99.0 %id)
BI054261 placenta_normal .a 2077 to 2471 389 to 5       385/389
(98 %)
0 diff
(100 %id)
DB362721   .a 2082 to 2642 559 to 1       559/560
(99 %)
5 diff
(99.2 %id)
DB368075   .a 2092 to 2642 550 to 1       550/550
(100 %)
8 diff
(98.6 %id)
BX366952   .a 2104 to 2999 889 to 1       889/889
(100 %)
5 diff
(99.5 %id)
BU183907 melanotic melanoma, skin .a 2106 to 2692 31 to 619       589/1046
(56 %)
20 diff
(98.1 %id)
BI053953 placenta_normal .a 2109 to 2424 342 to 30       313/342
(91 %)
0 diff
(100 %id)
BX113524 liver and spleen .a 2117 to 2813 1 to 697   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 697/697
(100 %)
1 diff
(99.9 %id)
R01296 liver and spleen .a 2117 to 2459 1 to 355   fully sequenced,   355/355
(100 %)
10 diff
(97.2 %id)
DB365153   .a 2117 to 2642 526 to 1       526/579
(90 %)
18 diff
(96.9 %id)
AL558812 T cells from T cell leukemia .a 2135 to 3008 869 to 1       869/869
(100 %)
5 diff
(99.5 %id)
R88757 liver and spleen .a 2136 to 2643 520 to 3       518/521
(99 %)
0 diff
(100 %id)
DB365816   .a 2137 to 2699 565 to 1       565/565
(100 %)
11 diff
(98.1 %id)
AA071433   .a 2145 to 2620 1 to 488       488/492
(99 %)
13 diff
(97.4 %id)
BG661288 Islets of Langerhans, Pancreas .a 2147 to 2689 1 to 544       544/544
(100 %)
5 diff
(99.1 %id)
AW007020 anaplastic oligodendroglioma, brain .a 2148 to 2642 495 to 1       495/495
(100 %)
0 diff
(100 %id)
CN363493 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2149 to 2534 1 to 386       386/386
(100 %)
0 diff
(100 %id)
BG287752 bladder, transitional cell papilloma, cell line .a 2161 to 2811 1 to 648   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 648/650
(99 %)
20 diff
(97.0 %id)
BP388115 pancreatic islet .a 2178 to 2646 1 to 469     Submitted on the opposite strand 469/469
(100 %)
0 diff
(100 %id)
FN147269 breast carcinoma .a 2195 to 2303 110 to 1     Submitted on the opposite strand 110/110
(100 %)
1 diff
(99.1 %id)
AA740894 germinal center B cell .a 2195 to 2593 399 to 1       399/399
(100 %)
2 diff
(99.5 %id)
AI087296 senescent fibroblast .a 2203 to 2642 460 to 21   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 440/440
(100 %)
1 diff
(99.8 %id)
AI762115 colon, colon tumor, RER+ .a 2205 to 2700 515 to 23   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 493/493
(100 %)
12 diff
(97.6 %id)
AL582587 B cells from Burkitt lymphoma .a 2214 to 2979 803 to 29       775/911
(85 %)
51 diff
(94.5 %id)
AA639573 colon, colon tumor RER+ .a 2215 to 2813 614 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 596/596
(100 %)
5 diff
(99.2 %id)
AW673743 cervix .a 2224 to 2644 421 to 1       421/421
(100 %)
0 diff
(100 %id)
BE302107 cervix .a 2224 to 2645 422 to 1       422/422
(100 %)
0 diff
(100 %id)
N28421 melanocyte .a 2233 to 2648 1 to 417       417/419
(99 %)
2 diff
(99.6 %id)
DB368894   .a 2234 to 2781 547 to 1       547/551
(99 %)
9 diff
(98.4 %id)
AI963705 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2249 to 2642 414 to 21   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 394/394
(100 %)
1 diff
(99.8 %id)
AW191063 adenocarcinoma, Pancreas .a 2249 to 2642 428 to 34   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 395/395
(100 %)
13 diff
(96.8 %id)
N35575 melanocyte .a 2254 to 2496 1 to 245       245/252
(97 %)
3 diff
(98.9 %id)
AW082616 colon, moderately differentiated adenocarcinoma .a 2257 to 2643 389 to 1       389/389
(100 %)
2 diff
(99.5 %id)
BG112925 Bone, osteosarcoma, cell line .a 2260 to 2943 1 to 681       681/682
(99 %)
14 diff
(98.0 %id)
AA706251 parathyroid gland, parathyroid tumor .a 2264 to 2687 435 to 12   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 424/424
(100 %)
0 diff
(100 %id)
CN363491 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2268 to 2955 1 to 689       689/689
(100 %)
6 diff
(99.2 %id)
AA536062 colon .a 2268 to 2657 1 to 390     Submitted on the opposite strand 390/486
(80 %)
13 diff
(97.4 %id)
BI492494 cochlea, ear .a 2281 to 2642 383 to 22   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 362/368
(98 %)
0 diff
(100 %id)
AW021536.
matches multiple genes
cochlea, ear .a 2281 to 2642 7 to 368   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base), also hits gene RBBP6 362/368
(98 %)
0 diff
(100 %id)
AA910229 Kidney .a 2286 to 2642 357 to 1       357/357
(100 %)
1 diff
(99.8 %id)
AA169634   .a 2292 to 2642 356 to 1       356/363
(98 %)
4 diff
(98.9 %id)
BU621058 cell lines, Chondrosarcoma .a 2292 to 3042 769 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 751/751
(100 %)
0 diff
(100 %id)
BQ270513 insulinoma, Pancreas .a 2302 to 2813 529 to 18   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 512/512
(100 %)
0 diff
(100 %id)
AW338398 adenocarcinoma, Pancreas .a 2313 to 2700 400 to 13   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 388/388
(100 %)
2 diff
(99.5 %id)
BF685821 leiomyosarcoma cell line, uterus .a 2313 to 2396 724 to 804       761/970
(78 %)
38 diff
(96.1 %id)
AI920903 adenocarcinoma, Pancreas .a 2319 to 2813 515 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 497/497
(100 %)
11 diff
(97.8 %id)
FN122911 breast carcinoma .a 2327 to 2436 110 to 1     Submitted on the opposite strand 110/110
(100 %)
0 diff
(100 %id)
BP386189 pancreatic islet .a 2331 to 2621 1 to 291     Submitted on the opposite strand 291/294
(98 %)
1 diff
(99.7 %id)
AW118427 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 2355 to 2644 292 to 1       292/292
(100 %)
5 diff
(98.3 %id)
DB552037 hippocampus .a 2360 to 2813 1 to 455     Submitted on the opposite strand 455/455
(100 %)
3 diff
(99.4 %id)
F04224 brain, total brain .a 2375 to 2696 323 to 1       323/323
(100 %)
1 diff
(99.7 %id)
AA627807 colon, colon tumor RER+ .a 2381 to 2703 325 to 6       320/325
(98 %)
0 diff
(100 %id)
R01185 liver and spleen .a 2429 to 2803 378 to 1   fully sequenced,   378/378
(100 %)
4 diff
(99.0 %id)
F04223 brain, total brain .a 2437 to 2696 261 to 1       261/261
(100 %)
1 diff
(99.7 %id)
BE207440 melanotic melanoma, skin .a 2501 to 2644 144 to 1       144/144
(100 %)
1 diff
(99.4 %id)
AI949225 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2528 to 3035 523 to 16   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 508/508
(100 %)
0 diff
(100 %id)
AW835015 leiomios .a 2534 to 2800 15 to 287       273/305
(89 %)
21 diff
(93.2 %id)
DB531410 hippocampus .a 2534 to 2813 1 to 281     Submitted on the opposite strand 281/281
(100 %)
3 diff
(99.0 %id)
CB217363 mandible, pooled .a 2540 to 3042 552 to 50   fully sequenced, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 503/503
(100 %)
1 diff
(99.9 %id)
AI859408 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 2552 to 3042 490 to 1       490/490
(100 %)
1 diff
(99.8 %id)
AA825497 germinal center B cell .a 2555 to 3035 489 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 471/472
(99 %)
11 diff
(97.7 %id)
AW173402 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2561 to 3039 476 to 1       476/476
(100 %)
1 diff
(99.8 %id)
AA975595 2 pooled tumors (clear cell type), Kidney .a 2573 to 3028 467 to 3       465/478
(97 %)
0 diff
(100 %id)
AI091417 pooled .a 2589 to 3043 459 to 4       456/459
(99 %)
0 diff
(100 %id)
DB537221 hippocampus .a 2604 to 3041 1 to 439     Submitted on the opposite strand 439/440
(99 %)
5 diff
(98.9 %id)
DB546474 hippocampus .a 2609 to 3034 1 to 426     Submitted on the opposite strand 426/427
(99 %)
1 diff
(99.8 %id)
AI983724 brain, three pooled meningiomas .a 2620 to 3035 416 to 1       416/474
(87 %)
2 diff
(99.6 %id)
AI815044 adenocarcinoma, Pancreas .a 2625 to 3039 415 to 1       415/415
(100 %)
0 diff
(100 %id)
AI039943   .a 2641 to 3035 408 to 14   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 395/395
(100 %)
2 diff
(99.5 %id)
AW078803 lung, cell line .a 2641 to 2831 191 to 1       191/191
(100 %)
4 diff
(98.0 %id)
AA973272 2 pooled tumors (clear cell type), Kidney .a 2643 to 3043 406 to 6   tiling clone,   401/406
(98 %)
0 diff
(100 %id)
AI887208 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 2644 to 3027 411 to 28   AAA   384/391
(98 %)
0 diff
(100 %id)
AI955440 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2645 to 3035 424 to 32   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 393/395
(99 %)
3 diff
(99.3 %id)
AW085235 pooled .a 2645 to 3043 401 to 3       399/401
(99 %)
0 diff
(100 %id)
AW769328 colon, moderately-differentiated adenocarcinoma .a 2649 to 3042 394 to 1       394/395
(99 %)
2 diff
(99.5 %id)
BF512138   .a 2663 to 3042 397 to 18   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 380/390
(97 %)
1 diff
(99.8 %id)
BF509045   .a 2663 to 3042 397 to 18   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 380/390
(97 %)
1 diff
(99.8 %id)
R37093 whole brain .a 2712 to 3039 332 to 2       331/338
(97 %)
0 diff
(100 %id)
Z41491 brain, total brain .a 2729 to 3042 314 to 1       314/314
(100 %)
0 diff
(100 %id)
AI701704 pooled .a 2733 to 3037 305 to 1       305/305
(100 %)
0 diff
(100 %id)
AI382320   .a 2741 to 3043 307 to 3       305/307
(99 %)
0 diff
(100 %id)
DB532367 hippocampus .a 2750 to 3035 1 to 285     Submitted on the opposite strand 285/285
(100 %)
19 diff
(93.4 %id)
F04902 brain, total brain .a 2760 to 3031 272 to 1       272/272
(100 %)
1 diff
(99.7 %id)
F01893 brain, total brain .a 2777 to 3031 255 to 1       255/255
(100 %)
2 diff
(99.3 %id)
AI370501   .a 2786 to 3035 250 to 1       250/250
(100 %)
0 diff
(100 %id)
D51659   .a 2794 to 3033 1 to 240       240/242
(99 %)
1 diff
(99.6 %id)
D51766   .a 2794 to 3035 1 to 242       242/242
(100 %)
0 diff
(100 %id)
D51963   .a 2794 to 3039 1 to 246       246/252
(97 %)
1 diff
(99.7 %id)
D52004   .a 2794 to 3035 1 to 242       242/242
(100 %)
0 diff
(100 %id)
BX385133   .a 2798 to 3039 1 to 242       242/242
(100 %)
0 diff
(100 %id)
D51907   .a 2803 to 3039 1 to 238       238/239
(99 %)
8 diff
(96.7 %id)
AA453912   .b 1 to 433 1 to 432   tiling clone,   432/432
(100 %)
1 diff
(99.8 %id)
AA453405   .b 989 to 1381 397 to 5   tiling clone,   393/397
(98 %)
0 diff
(100 %id)
TI_57238348   .c 1 to 830 33 to 864   tiling clone,   832/864
(96 %)
13 diff
(98.5 %id)
BI912683 brain .c 5 to 830 1 to 828   tiling clone,   828/828
(100 %)
7 diff
(99.2 %id)
CN363492 embryonic stem cells, cell lines H1, H7, andH9 .c 704 to 1333 1 to 632   tiling clone,   632/632
(100 %)
4 diff
(99.4 %id)
CR613606 adult brain .d 1 to 1662 1 to 1662 exact tiling clone,   1662/1662
(100 %)
0 diff
(100 %id)
AL532885 adult brain, brain .d 1 to 1055 1 to 1041       1041/1094
(95 %)
19 diff
(98.3 %id)
BU507373 leiomyosarcoma, uterus .d 10 to 834 1 to 830       830/842
(98 %)
6 diff
(99.3 %id)
BF206705 brain, neuroblastoma .d 52 to 780 1 to 717       721/899
(80 %)
27 diff
(97.0 %id)
AA449625   .d 53 to 523 1 to 470       470/470
(100 %)
1 diff
(99.8 %id)
AA233437 brain, neuroepithelial cells .d 64 to 335 1 to 271       271/271
(100 %)
3 diff
(98.9 %id)
AA449364   .d 845 to 1263 418 to 1       418/418
(100 %)
1 diff
(99.8 %id)
AA252314 brain, neuroepithelial cells .d 1887 to 2147 261 to 1   tiling clone,   261/261
(100 %)
0 diff
(100 %id)
BP241341 Liver .e 1 to 572 1 to 572   tiling clone,   572/572
(100 %)
4 diff
(99.4 %id)
BP241443 Liver .e 1 to 579 1 to 579   tiling clone,   579/579
(100 %)
2 diff
(99.7 %id)
AK300778   .e 31 to 1478 1 to 1448 exact tiling clone,   1448/1448
(100 %)
0 diff
(100 %id)
DC386563   .e 31 to 554 1 to 524       524/524
(100 %)
0 diff
(100 %id)
CN363498 embryonic stem cells, DMSO-treated H9 cellline .f 1 to 790 1 to 791 M140R tiling clone,   791/791
(100 %)
3 diff
(99.7 %id)
CA411699 Chondrosarcoma Grade II, Left Pelvis .f 255 to 845 611 to 21   tiling clone, AAA   591/591
(100 %)
5 diff
(99.2 %id)
AA876364 2 pooled tumors (clear cell type), Kidney .f 826 to 1238 416 to 4   tiling clone,   413/416
(99 %)
0 diff
(100 %id)
AI191796   .f 898 to 1239 359 to 18   tiling clone,   342/359
(95 %)
0 diff
(100 %id)
AI374649   .f 960 to 1239 291 to 12   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 280/280
(100 %)
2 diff
(99.3 %id)
CR608187 B cells (Ramos cell line) Cot 25-normalized .g 1 to 1373 1 to 1373 exact tiling clone,   1373/1373
(100 %)
0 diff
(100 %id)
BX344707   .g 1 to 1159 1 to 1147 Q138X M140R     1147/1147
(100 %)
24 diff
(98.0 %id)
BX385100   .g 1 to 1098 1 to 1093 M140R     1093/1093
(100 %)
15 diff
(98.7 %id)
BG753051 eye, normal pigmented retinal epithelium .g 12 to 839 1 to 825 D172E V179C A180G L206H S207L ...     825/826
(99 %)
14 diff
(98.4 %id)
CR620062 fetal liver .g 36 to 1396 1 to 1361 exact     1361/1361
(100 %)
0 diff
(100 %id)
BX427255 fetal liver, Liver .g 36 to 541 1 to 506   fully sequenced,   506/506
(100 %)
0 diff
(100 %id)
BG475580 melanotic melanoma, skin .g 39 to 942 1 to 897 E92A L94R F95Y P96F D97L ...     897/930
(96 %)
32 diff
(96.6 %id)
BQ954274 leiomyosarcoma, uterus .g 44 to 880 1 to 845 E186R V187S V188C L189P W190L ...     845/870
(97 %)
18 diff
(98.0 %id)
BQ669897 epidermoid carcinoma, cell line, salivary gland .g 46 to 951 1 to 916 Q138H Q139R M140G R167X W182*     916/940
(97 %)
41 diff
(95.7 %id)
AA256647 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .g 50 to 134 1 to 84       84/84
(100 %)
1 diff
(98.9 %id)
AW953467   .g 59 to 822 11 to 774 M140R N211K G212W R213K     764/774
(98 %)
9 diff
(98.9 %id)
BM559420 amelanotic melanoma, cell line, skin .g 163 to 984 1 to 822   AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 822/822
(100 %)
4 diff
(99.6 %id)
BQ440179 melanotic melanoma, skin .g 166 to 918 12 to 766       755/872
(86 %)
12 diff
(98.7 %id)
BX344706   .g 213 to 1373 1153 to 1       1153/1153
(100 %)
60 diff
(94.8 %id)
AI541176 Tissue culture .g 249 to 984 732 to 1       732/742
(98 %)
29 diff
(96.1 %id)
BX348905 Placenta Cot 25-normalized .g 329 to 1169 1 to 849       849/941
(90 %)
36 diff
(96.2 %id)
BX348904 Placenta Cot 25-normalized .g 330 to 1033 1 to 708       708/937
(75 %)
55 diff
(94.2 %id)
R00170 liver and spleen .g 379 to 630 10 to 263       254/410
(61 %)
12 diff
(97.1 %id)
BI439588 Pancreas, Purified pancreatic islet .g 422 to 992 571 to 1       571/574
(99 %)
3 diff
(99.5 %id)
TI_153957105   .g 463 to 1237 79 to 856   AAA   778/946
(82 %)
79 diff
(91.7 %id)
BX427254 fetal liver, Liver .g 511 to 1387 886 to 10   fully sequenced,   877/886
(98 %)
1 diff
(99.9 %id)
BM311455 Pancreas, Purified pancreatic islet .g 515 to 991 477 to 1       477/477
(100 %)
3 diff
(99.4 %id)
AI753358 bone marrow stroma .g 525 to 1003 479 to 1       479/479
(100 %)
3 diff
(99.4 %id)
R67734 placenta .g 536 to 993 1 to 462       462/462
(100 %)
18 diff
(96.2 %id)
AW971230   .g 584 to 1014 533 to 103     Submitted on the opposite strand 431/549
(78 %)
1 diff
(99.9 %id)
AA493570 thyroid .g 584 to 999 416 to 1       416/421
(98 %)
1 diff
(99.8 %id)
CA444021 Fibrosarcoma .g 592 to 992 417 to 17   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 401/401
(100 %)
0 diff
(100 %id)
AI357750 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .g 598 to 992 395 to 1       395/395
(100 %)
1 diff
(99.8 %id)
TI_149295763   .g 634 to 1416 874 to 100   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 775/925
(83 %)
16 diff
(98.3 %id)
AA256664 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .g 656 to 986 331 to 1       331/331
(100 %)
0 diff
(100 %id)
R00171 liver and spleen .g 679 to 991 318 to 3       316/324
(97 %)
0 diff
(100 %id)
BU184642 melanotic melanoma, cell line, skin .g 713 to 1412 1 to 703   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 703/703
(100 %)
11 diff
(98.5 %id)
BF843969 head_neck .g 743 to 871 130 to 2     Submitted on the opposite strand 129/136
(94 %)
0 diff
(100 %id)
AA862554 pooled germ cell tumors .g 746 to 992 247 to 1       247/247
(100 %)
0 diff
(100 %id)
BG027749 Bone, osteosarcoma, cell line .g 793 to 1412 1 to 616       616/635
(97 %)
15 diff
(97.7 %id)
BU683872 lung, Primary Lung Cystic Fibrosis EpithelialCells .g 800 to 1416 635 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 617/617
(100 %)
0 diff
(100 %id)
BI792371 Pancreas, Purified pancreatic islet .g 859 to 1411 553 to 1       553/553
(100 %)
0 diff
(100 %id)
AI718010 aorta .g 914 to 1403 498 to 8       491/498
(98 %)
0 diff
(100 %id)
AI016577   .g 915 to 1423 513 to 5   tiling clone,   509/513
(99 %)
0 diff
(100 %id)
BQ008300 Chondrosarcoma, Left Pelvis .g 918 to 1416 517 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 499/499
(100 %)
3 diff
(99.4 %id)
AA481439 ovarian tumor, ovary .g 969 to 1412 461 to 17   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 445/445
(100 %)
3 diff
(99.4 %id)
AA507043 breast .g 998 to 1416 419 to 1       419/428
(97 %)
0 diff
(100 %id)
AI288835 2 pooled tumors (clear cell type), Kidney .g 1012 to 1414 404 to 2       403/405
(99 %)
0 diff
(100 %id)
AA515030 colon .g 1021 to 1414 397 to 4       394/397
(99 %)
0 diff
(100 %id)
AW302590 brain, three pooled meningiomas .g 1032 to 1412 381 to 1       381/381
(100 %)
1 diff
(99.8 %id)
BU566396 mixed (pool of 40 RNAs) .g 1044 to 1412 1 to 369       369/373
(98 %)
2 diff
(99.5 %id)
AI299930 2 pooled tumors (clear cell type), Kidney .g 1045 to 1414 371 to 2       370/371
(99 %)
0 diff
(100 %id)
AA863055 2 pooled tumors (clear cell type), Kidney .g 1047 to 1414 368 to 2       367/368
(99 %)
0 diff
(100 %id)
BI493749 cochlea, ear .g 1056 to 1412 1 to 357   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 357/357
(100 %)
4 diff
(98.9 %id)
AI758382 Kidney .g 1091 to 1414 330 to 7       324/330
(98 %)
0 diff
(100 %id)
BF059341 pooled germ cell tumors .g 1117 to 1412 296 to 1       296/296
(100 %)
2 diff
(99.4 %id)
AW977663   .g 1121 to 1408 292 to 5     Submitted on the opposite strand 288/481
(59 %)
0 diff
(100 %id)
AA810762 germinal center B cell .g 1121 to 1412 315 to 24   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 292/456
(64 %)
2 diff
(99.6 %id)
AA812147 germinal center B cell .g 1121 to 1412 314 to 24   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 291/398
(73 %)
1 diff
(99.8 %id)
R66124 placenta .g 1123 to 1414 303 to 6       298/308
(96 %)
0 diff
(100 %id)
AI375885 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .g 1189 to 1411 223 to 1       223/431
(51 %)
0 diff
(100 %id)
BI465053 testis .h 1 to 723 1 to 723   tiling clone,   723/723
(100 %)
3 diff
(99.6 %id)
DC396201 testis .h 58 to 632 1 to 576       576/576
(100 %)
2 diff
(99.7 %id)
BM462023 eye, retinoblastoma .h 619 to 1599 1 to 985 L134Y F135S S136P W138G R139D ... tiling clone,   985/1069
(92 %)
30 diff
(97.2 %id)
CN363494 embryonic stem cells, DMSO-treated H9 cellline .i 1 to 706 1 to 706   tiling clone,   706/706
(100 %)
0 diff
(100 %id)
AI025786   .i 520 to 957 437 to 1   tiling clone,   437/437
(100 %)
2 diff
(99.6 %id)
CO401500 Chondrosarcoma Lung Metastasis cell lines, lung .j -10 to 720 1 to 724 V134S L135S W136G L137W E138S ... tiling clone,   724/815
(88 %)
13 diff
(98.5 %id)
CR603825 neuroblastoma .k 1 to 1177 1 to 1177 exact tiling clone,   1177/1177
(100 %)
0 diff
(100 %id)
AL515859 brain, neuroblastoma, neuroblastoma cells .k 1 to 1084 1 to 1081 exact     1081/1127
(95 %)
14 diff
(98.8 %id)
BX437923 neuroblastoma .k 1 to 697 1 to 697 exact     697/697
(100 %)
0 diff
(100 %id)
BM051099 eye, normal pigmented retinal epithelium .k 61 to 794 1 to 733 T95I K135N Y138I L139*     733/737
(99 %)
7 diff
(99.1 %id)
AL515858 brain, neuroblastoma, neuroblastoma cells .k 106 to 1177 1066 to 1 E2L E3S P4K Q5A K6X ...     1066/1069
(99 %)
35 diff
(96.8 %id)
CB140095 Liver .k 248 to 632 1 to 385       385/385
(100 %)
1 diff
(99.8 %id)
BE670620 carcinoid, lung .l-u 1 to 424 432 to 8   tiling clone,   425/432
(98 %)
0 diff
(100 %id)
BI030891 marrow .l-u 370 to 640 271 to 1   tiling clone,   271/271
(100 %)
0 diff
(100 %id)
DW424188 Liver .l-u 424 to 671 17 to 264   tiling clone, AAA   248/264
(93 %)
6 diff
(97.8 %id)
CN363495 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .m 1 to 650 1 to 650 P2A L4V tiling clone,   650/650
(100 %)
6 diff
(99.1 %id)
BE670387 carcinoid, lung .n 1 to 475 1 to 475   tiling clone, Submitted on the opposite strand 475/475
(100 %)
2 diff
(99.6 %id)
CR992350 T-Lymphocytes .n 167 to 930 30 to 795 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 795/795
(100 %)
10 diff
(98.8 %id)
M78938   .n 280 to 471 1 to 192       192/193
(99 %)
1 diff
(99.5 %id)
AI890440 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .o-u 1 to 411 490 to 80 F16X tiling clone,   411/490
(83 %)
0 diff
(100 %id)
AA321090 adipose tissue, brown Gene BFAR, variant not shown              
AA321091 adipose tissue, brown Gene BFAR, variant not shown              
AK297067 cord Blood Gene BFAR, variant not shown         Suspected internal deletion, this clone was ignored    
DB307936 hippocampus Gene BFAR, variant not shown              
DA298872 hippocampus Gene BFAR, variant not shown       capped      
AL524573 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized Gene BFAR, variant not shown         This clone was ignored    
AL524574 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized Gene BFAR, variant not shown         This clone was ignored    
DC297294   Gene BFAR, variant not shown         Suspected internal deletion, this clone was ignored    
DB315241 brain Gene BFAR, variant not shown         This clone was ignored    
DA487739 brain Gene BFAR, variant not shown       capped This clone was ignored    
AA741576 germinal center B cell Gene BFAR, variant not shown       AAA This clone was ignored    
AA962493 2 pooled tumors (clear cell type), Kidney Gene BFAR, variant not shown         Suspected internal deletion, this clone was ignored    
AI359043 brain, glioblastoma (pooled) Gene BFAR, variant not shown         This clone was ignored    
AI421512 brain, glioblastoma (pooled) Gene BFAR, variant not shown         This clone was ignored    
AI825391 pooled germ cell tumors Gene BFAR, variant not shown         This clone was ignored    
BE466602 pooled germ cell tumors Gene BFAR, variant not shown         This clone was ignored    
BF939656 brain, glioblastoma (pooled) Gene BFAR, variant not shown         This clone was ignored    
BE536961 cervix Gene BFAR, variant not shown         This clone was ignored    
BF315886 brain, neuroblastoma Gene BFAR, variant not shown         Suspected internal deletion, this clone was ignored    
CD641080 pooled Gene BFAR, variant not shown       AAA This clone was ignored    
DB368201   Gene BFAR, variant not shown         Suspected internal deletion, this clone was ignored    
DA735845   Gene BFAR, variant not shown       capped Suspected internal deletion, this clone was ignored    
TI_151750788   Gene BFAR, variant not shown         Suspected internal deletion, this clone was ignored    
TI_151793558   Gene BFAR, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l-u, .m, .n, .o-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI